Literature DB >> 1197763

Infection of neonates and infants with the hepatitis B virus.

I L Schweitzer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1197763

Source DB:  PubMed          Journal:  Prog Med Virol        ISSN: 0079-645X


× No keyword cloud information.
  9 in total

1.  Extrahepatic manifestations of hepatitis B virus infection: Addison's disease and myelofibrosis in a patient with persistent hepatitis B surface antigenemia.

Authors:  F Somlo; G R Berry
Journal:  Can J Infect Dis       Date:  1993-05

Review 2.  Pregnancy and liver disease.

Authors:  M M Steven
Journal:  Gut       Date:  1981-07       Impact factor: 23.059

3.  Lack of supportive evidence for an autosomal recessive inheritance in chronic hepatitis B infections.

Authors:  M J Tong; J M Weiner
Journal:  Dig Dis Sci       Date:  1979-04       Impact factor: 3.199

4.  Epidemiology of hepatitis B infection in Liberian infants.

Authors:  A M Prince; T White; N Pollock; J Riddle; B Brotman; L Richardson
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

5.  Perinatal transmission of hepatitis B virus.

Authors:  R K Chaudhary
Journal:  Can Med Assoc J       Date:  1983-03-15       Impact factor: 8.262

6.  Chronic hepatitis type B in childhood: longitudinal study of 35 cases.

Authors:  F Bortolotti; P Cadrobbi; C Crivellaro; A Bertaggia; A Alberti; G Realdi
Journal:  Gut       Date:  1981-06       Impact factor: 23.059

7.  A 7 year survey of acute hepatitis type B.

Authors:  F Bortolotti; P Cadrobbi; A Bertaggia; L Rude; A Alberti; G Realdi
Journal:  Arch Dis Child       Date:  1983-12       Impact factor: 3.791

8.  Prognosis of chronic hepatitis B transmitted from HBsAg positive mothers.

Authors:  F Bortolotti; P Cadrobbi; M Armigliato; L Rude; M Rugge; G Realdi
Journal:  Arch Dis Child       Date:  1987-02       Impact factor: 3.791

9.  Infection with hepatitis B virus in infancy. A longitudinal study of 8 cases.

Authors:  P Skinhøj
Journal:  Arch Dis Child       Date:  1978-09       Impact factor: 3.791

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.